Exploring the development of benzimidazole-1,2,3-triazole hybrid molecules as multi-target cancer therapies that overcome drug resistance.
Explore how scientists are creating hybrid molecules like tetrahydroquinoline-isoxazole compounds to develop targeted cancer therapies with precision and reduced side effects.
Explore how quinazoline and quinazolinone hybrids are revolutionizing drug discovery with their multifaceted therapeutic potential against cancer, inflammation, and microbial infections.